AUTHOR=Celhar Teja , Lu Hao Kim , Benso Lia , Rakhilina Larissa , Lee Hui Yin , Tripathi Shubhita , Zharkova Olga , Ong Wei Yee , Yasuga Hiroko , Au Bijin , Marlier Damien , Lim Lina Hsiu Kim , Thamboo Thomas Paulraj , Mudgett John S. , Mackey Matthew F. , Zaller Dennis M. , Connolly John E. , Fairhurst Anna-Marie TITLE=TLR7 Protein Expression in Mild and Severe Lupus-Prone Models Is Regulated in a Leukocyte, Genetic, and IRAK4 Dependent Manner JOURNAL=Frontiers in Immunology VOLUME=10 YEAR=2019 URL=https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2019.01546 DOI=10.3389/fimmu.2019.01546 ISSN=1664-3224 ABSTRACT=
The global increase in autoimmunity, together with the emerging autoimmune-related side effects of cancer immunotherapy, have furthered a need for understanding of immune tolerance and activation. Systemic lupus erythematosus (SLE) is the archetypical autoimmune disease, affecting multiple organs, and tissues. Studying SLE creates knowledge relevant not just for autoimmunity, but the immune system in general. Murine models and patient studies have provided increasing evidence for the innate immune toll like receptor-7 (TLR7) in disease initiation and progression. Here, we demonstrated that the kinase activity of the TLR7-downstream signaling molecule, interleukin-1 receptor associated kinase 4 (IRAK4), is essential for mild and severe autoimmune traits of the